Read More Pharma Industry News BeiGene’s BRUKINSA gains accelerated FDA approval for follicular lymphoma treatment In a significant development for patients with relapsed or refractory follicular lymphoma, BeiGene, Ltd. has announced the U.S.… byPallavi MadhirajuMarch 8, 2024